BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1389 related articles for article (PubMed ID: 23764081)

  • 1. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
    Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Brown BT; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
    J Urol; 2013 Dec; 190(6):2161-7. PubMed ID: 23764081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift.
    McVary KT; Gange SN; Shore ND; Bolton DM; Cowan BE; Brown BT; Te AE; Chin PT; Rukstalis DB; Roehrborn CG;
    J Sex Med; 2014 Jan; 11(1):279-87. PubMed ID: 24119101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Cantwell AL; Bogache WK; Richardson SF; Tutrone RF; Barkin J; Fagelson JE; Chin PT; Woo HH
    BJU Int; 2014 Apr; 113(4):615-22. PubMed ID: 24765680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Woo HH; Bolton DM; Laborde E; Jack G; Chin PT; Rashid P; Thavaseelan J; McVary KT
    J Sex Med; 2012 Feb; 9(2):568-75. PubMed ID: 22172161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham.
    Rukstalis D; Rashid P; Bogache WK; Tutrone RF; Barkin J; Chin PT; Woo HH; Cantwell AL; Cowan BE; Bolton DM
    BJU Int; 2016 Oct; 118 Suppl 3():14-22. PubMed ID: 27684483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
    McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
    Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Bozkurt A; Karabakan M; Keskin E; Hirik E; Balci MB; Nuhoglu B
    Urol Int; 2016; 96(2):202-6. PubMed ID: 26613256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three year results of the prostatic urethral L.I.F.T. study.
    Roehrborn CG; Rukstalis DB; Barkin J; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rashid P
    Can J Urol; 2015 Jun; 22(3):7772-82. PubMed ID: 26068624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.
    Roehrborn CG; Barkin J; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Herron S; Rashid P; Rukstalis DB
    Can J Urol; 2017 Jun; 24(3):8802-8813. PubMed ID: 28646935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective multi-center study elucidating patient experience after prostatic urethral lift.
    Shore N; Freedman S; Gange S; Moseley W; Heron S; Tutrone R; Brown T; Barkin J
    Can J Urol; 2014 Feb; 21(1):7094-101. PubMed ID: 24529008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; Reddy B; McCutcheon KA; Borofsky M; Narayan V; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012832. PubMed ID: 31128077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Chin PT; Bolton DM; Jack G; Rashid P; Thavaseelan J; Yu RJ; Roehrborn CG; Woo HH
    Urology; 2012 Jan; 79(1):5-11. PubMed ID: 22202539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
    Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
    Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
    World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study.
    McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
    J Sex Med; 2016 Jun; 13(6):924-33. PubMed ID: 27129767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
    J Urol; 2016 May; 195(5):1529-1538. PubMed ID: 26614889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durability of the Prostatic Urethral Lift: 2-Year Results of the L.I.F.T. Study.
    Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
    Urol Pract; 2015 Jan; 2(1):26-32. PubMed ID: 37537806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study.
    Sønksen J; Barber NJ; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Montorsi F; Patterson JM; Fahrenkrug L; Schoenthaler M; Gratzke C
    Eur Urol; 2015 Oct; 68(4):643-52. PubMed ID: 25937539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic Urethral Lift for Obstructive Median Lobes: Consistent Results Across Controlled Trial and Real-World Settings.
    Eure G; Rukstalis D; Roehrborn C
    J Endourol; 2023 Jan; 37(1):50-59. PubMed ID: 35876440
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
    Woo HH; Chin PT; McNicholas TA; Gill HS; Plante MK; Bruskewitz RC; Roehrborn CG
    BJU Int; 2011 Jul; 108(1):82-8. PubMed ID: 21554526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.